PREDIGEN
Dead / Abandoned — Abandoned — failure to respond (as of 01 Jun 2023)
What this means for you
This application is over — abandoned 12 Apr 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97315169
- Mark type
- Stylized text
- Filed
- 16 Mar 2022
- Abandoned
- 12 Apr 2023
- Attorney of record
- Susanna P. Lichter
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic testing materials, diagnostic preparations for medical testing purposes, diagnostic preparations, and diagnostic reagents all for the detection and diagnosis of Covid-19; diagnostic testing materials for the detection and diagnosis of viral, bacterial and fungal infections, sepsis, cardiovascular disease, radiation exposure, autoimmune and inflammatory disease and cancer
- Class 042 — Scientific and technological services: Biotechnology research; research and development of vaccines and medicines for the treatment of Covid-19; consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science laboratory testing, diagnostics, and pharmacogenetics research; development of new technology for others in the field of biotechnology
- Class 044 — Medical, beauty and agricultural services: Medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes for diagnosis of Covid-19; medical testing for diagnostic or treatment purposes for diagnosis of viral, bacterial and fungal infections, sepsis, cardiovascular disease, radiation exposure, autoimmune and inflammatory disease and cancer
Owner
- Biomeme, Inc., Philadelphia, PA, US
Prosecution history
- 01 Jun 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 01 Jun 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 01 Jun 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 11 Jan 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Jan 2023 — NON-FINAL ACTION E-MAILED
- 11 Jan 2023 — NON-FINAL ACTION WRITTEN
- 04 Jan 2023 — ASSIGNED TO EXAMINER
- 22 Mar 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Mar 2022 — NEW APPLICATION ENTERED